Mechanism-based design of 2,3-benzodiazepine inhibitors for AMPA receptors
2,3-Benzodiazepine (2,3-BDZ) compounds represent a group of structurally diverse, small-molecule antagonists of (R, S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptors. Antagonists of AMPA receptors are drug candidates for potential treatment of a number of neurological dis...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-11-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221138351500115X |
id |
doaj-6088c84040eb484987e556109c801efe |
---|---|
record_format |
Article |
spelling |
doaj-6088c84040eb484987e556109c801efe2020-11-24T23:04:52ZengElsevierActa Pharmaceutica Sinica B2211-38352211-38432015-11-015650050510.1016/j.apsb.2015.07.007Mechanism-based design of 2,3-benzodiazepine inhibitors for AMPA receptorsLi Niu2,3-Benzodiazepine (2,3-BDZ) compounds represent a group of structurally diverse, small-molecule antagonists of (R, S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptors. Antagonists of AMPA receptors are drug candidates for potential treatment of a number of neurological disorders such as epilepsy, stroke and amyotrophic lateral sclerosis (ALS). How to make better inhibitors, such as 2,3-BDZs, has been an enduring quest in drug discovery. Among a few available tools to address this specific question for making better 2,3-BDZs, perhaps the best one is to use mechanistic clues from studies of the existing antagonists to design and discover more selective and more potent antagonists. Here I review recent work in this area, and propose some ideas in the continuing effort of developing newer 2,3-BDZs for tighter control of AMPA receptor activities in vivo.http://www.sciencedirect.com/science/article/pii/S221138351500115XAMPA receptors2,3-Benzodiazepine derivativesSubunit-selective antagonistsRNA aptamers |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Li Niu |
spellingShingle |
Li Niu Mechanism-based design of 2,3-benzodiazepine inhibitors for AMPA receptors Acta Pharmaceutica Sinica B AMPA receptors 2,3-Benzodiazepine derivatives Subunit-selective antagonists RNA aptamers |
author_facet |
Li Niu |
author_sort |
Li Niu |
title |
Mechanism-based design of 2,3-benzodiazepine inhibitors for AMPA receptors |
title_short |
Mechanism-based design of 2,3-benzodiazepine inhibitors for AMPA receptors |
title_full |
Mechanism-based design of 2,3-benzodiazepine inhibitors for AMPA receptors |
title_fullStr |
Mechanism-based design of 2,3-benzodiazepine inhibitors for AMPA receptors |
title_full_unstemmed |
Mechanism-based design of 2,3-benzodiazepine inhibitors for AMPA receptors |
title_sort |
mechanism-based design of 2,3-benzodiazepine inhibitors for ampa receptors |
publisher |
Elsevier |
series |
Acta Pharmaceutica Sinica B |
issn |
2211-3835 2211-3843 |
publishDate |
2015-11-01 |
description |
2,3-Benzodiazepine (2,3-BDZ) compounds represent a group of structurally diverse, small-molecule antagonists of (R, S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptors. Antagonists of AMPA receptors are drug candidates for potential treatment of a number of neurological disorders such as epilepsy, stroke and amyotrophic lateral sclerosis (ALS). How to make better inhibitors, such as 2,3-BDZs, has been an enduring quest in drug discovery. Among a few available tools to address this specific question for making better 2,3-BDZs, perhaps the best one is to use mechanistic clues from studies of the existing antagonists to design and discover more selective and more potent antagonists. Here I review recent work in this area, and propose some ideas in the continuing effort of developing newer 2,3-BDZs for tighter control of AMPA receptor activities in vivo. |
topic |
AMPA receptors 2,3-Benzodiazepine derivatives Subunit-selective antagonists RNA aptamers |
url |
http://www.sciencedirect.com/science/article/pii/S221138351500115X |
work_keys_str_mv |
AT liniu mechanismbaseddesignof23benzodiazepineinhibitorsforampareceptors |
_version_ |
1725628820769210368 |